Oral colonization of Candida species in patients receiving radiotherapy in the head and neck area

Quintessence International

Volumn 39, Issue 2, 2008, Pages e52-e57

  Thaweboon, Sroisiri ^a   Thaweboon, Boonyanit ^a   Srithavaj, Theerathavaj ^a   Choonharuangdej, Suwan ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Candida; Oral colonization; Radiotherapy

Indexed keywords

CHROMOGENIC SUBSTRATE; DIAGNOSTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CASE CONTROL STUDY; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; GROWTH, DEVELOPMENT AND AGING; HEAD AND NECK TUMOR; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MOUTH; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; THRUSH;

ADOLESCENT; ADULT; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS, ORAL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOGENIC COMPOUNDS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH; RADIOTHERAPY DOSAGE;

EID: 49849092039     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chen TY, Webster JH. Oral monilia study in patients with head and neck cancer during radiotherapy. Cancer 1974;34:246-249.
2. Redding SW, Zellars RC, Kirkpatrick RK, et al. Epidemiology of oropharyngeal candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 1999;37:3896-3900.
3. Chen KY, Fletcher GH. Malignant tumors of nasopharynx. Radiology 1971;99:165-171.
4. Spiechowiez E, Rusiniak-Kubik K, Skopinska-Rozewska E, et al. Immunological status of patients with denture stomatitis and yeast infection after treatment of maxillofacial tumors. Arch Immunol Ther Exp 1994;42:263-267.
5. Fotos PG, Hellstein JW. Candida and candidosis:Epidemiology, diagnosis, and therapeutic management. Dent Clin North Am 1992;36:857-878.
6. Redding SW, Kirkpatrick WR, Dib O, Fothergill AW, Rinaldi MG, Patterson TF. The epidemiology of nonalbicans Candida in oropharyngeal candidosis in HIV patients. Spec Care Dentist 2000;20:178-181.
7. Arendorf TM, Walker DM. Oral candidal populations in health and disease. Br Dent J 1979;147:267-272.
8. Pinjoin E, Sullivan D, Salkin I, Shanley D, Coleman D. Simple inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 1998;36:2093-2095.
9. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
10. Remirez-Amador V, Silverman S, Mayer JP, Tyler M, Guivey J.Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:149-153.
11. Leung WK, Dassanayake RS, Yau JY, Jin LJ, Yam WC, Samaranayake LP. Oral colonization, phenotypic and genotypic profiles of Candida species in irradiated, dentate, xerostomic nasopharyngeal carcinoma survivors. J Clin Microbiol 2000;38:2219-2226.
12. Fidel PL, Vazquez JA, Sobel JD. Candida glabrata:Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999;12:80-96.
13. Boschman CR, Bodnar UR, Tomatore MA, et al. Thirteen years evolution of azole resistance in yeast isolates and prevalence of resistance strains carried by cancer patients at a large medical center. Antimicrob Agents Chemother 1998;42:734-738.
14. Redding SP, Rinaldi MG, Hicks JL.The relationship of oral Candida tropicalis infection to systemic candidiasis in a patient with leukemia. Spec Care Dentist 1988;8:111-114.
15. Samaranayake LP.Candida krusei infections and fluconazole therapy. Hong Kong Med J 1997;3:312-314.
16. Sullivan DJ, Westerneng TJ, Haynes KA, Bennet DE, Coleman DC. Candida dubliniensis sp. nov.:Phenotypic and molecular characterization of a novel species associated with oral candidiasis in HIV-infected individuals. Microbiology 1995;141:1507-1521.
17. Dahiya MC et al. Oropharyngeal candidiasis caused by non-albicans yeast in patient receiving external beam radiotherapy for head-and-neck cancer. Int J Radiation Oncology Biol Phys 2003;57:79-83.
18. Redding SW. The role of yeast other than Candida albicans in oropharyngeal candidiasis. Curr Opin Infect Dis 2001;14:673-677.
19. Fotedar R, Al-Hedaithy SS.Candida dubliniensis at a university hospital in Saudi Arabia. J Clin Microbiol 2003;41:1907-1911.
20. Gottlieb GS, Limaye AP, Chen YC, Van Voorhis WC. Candida dubliniensis fungemia in a solid organ transplant patient:Case report and review of the literature. Med Mycol 2001;39:483-485.
21. Gutierrez J, Morales P, Gonzalez MA, Quindos G. Candida dubliniensis, a new fungal pathogen. J Basic Microbiol 2002;42:207-227.
22. Odds FC, Van Nuffel L, Dams G. Prevalence of Candida dubliniensis isolates in yeast stock collection. J Clin Microbiol 1998;36:2869-2873.
23. Gales AC, Pfaller MA, Houston AK, et al. Identification of Candida dubliniensis based on temperature and utilization of xylose and alphamethyl-D-gluciside as determined with the API 20C AUX and Vitek YBC systems. J Clin Microbiol 1999;37:3804-3808.
24. Sancak B, Rex JH, Paetznick V, Chen E, Rodriquez J. Evaluation of a method for identification of Candida dubliniensis bloodstream isolates. J Clin Microbiol 2003;41:489-491.
25. Gee SF, Joly S, Soll DR, et al. Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo. J Clin Microbiol 2002;40:556-74.
26. Neppelenbroek KH, Campanha NH, Spolidorio LC, Seo RS, Pavarina AC.Molecular fingerprinting methods for discrimination between C. albicans and C. Dubliniensis. Oral Dis 2006;12:242-253.